NCT00379730View on ClinicalTrials.gov

Prednisolone Novel Endpoint Study in Patients With Chronic Obstructive Pulmonary Disease (COPD)

PHASE1CompletedINTERVENTIONAL

Enrollment

90

Participants

Timeline

Start Date

March 21, 2006

Study Completion Date

May 3, 2007

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Prednisolone

Trial Locations (5)

6035

GSK Investigational Site, Wellington

7700

GSK Investigational Site, Mowbray

7500551

GSK Investigational Site, Santiago

7500691

GSK Investigational Site, Santiago

M5500CCG

GSK Investigational Site, Mendoza

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY